Nutri Pharmaceuticals Research, Inc. (NRPR)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0200 (-44.44%)
At close: Jun 11, 2025

NRPR Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2003 FY 2002
Period Ending
Sep '04 Dec '03 Dec '02
Revenue
1.210.13-
Cost of Revenue
0.70.110
Gross Profit
0.510.02-0
Selling, General & Admin
0.930.160
Operating Expenses
0.970.170.01
Operating Income
-0.46-0.15-0.01
Interest Expense
-0.01-0-
Other Non Operating Income (Expenses)
-0-00
Pretax Income
-0.47-0.16-0.01
Net Income
-0.47-0.16-0.01
Net Income to Common
-0.47-0.16-0.01
Shares Outstanding (Basic)
100
Shares Outstanding (Diluted)
100
Shares Change (YoY)
-30.03%-
EPS (Basic)
-0.65-1.64-0.10
EPS (Diluted)
-0.65-1.64-0.10
Free Cash Flow
-0.010.03-0.01
Free Cash Flow Per Share
-0.010.36-0.07
Gross Margin
42.07%15.05%-
Operating Margin
-38.26%-121.51%-
Profit Margin
-38.61%-124.94%-
Free Cash Flow Margin
-0.77%27.34%-
EBITDA
-0.42-0.14-0
EBITDA Margin
-34.95%-114.56%-
D&A For EBITDA
0.040.010
EBIT
-0.46-0.15-0.01
EBIT Margin
-38.26%-121.51%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.